Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferran Navarro

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica|June 24, 2011
[Detection of resistance phenotypes in gram-negative bacteria]Ferran Navarro, Jorge Calvo, Rafael Cantón, et al.
Applied and Environmental Microbiology|June 11, 2013
Shiga toxin 2-encoding bacteriophages in human fecal samples from healthy individualsAlexandre Martinez-Castillo, Pablo Quirós, Ferran Navarro, et al.
The Journal of Antimicrobial Chemotherapy|September 29, 2005
Characterization of the highly variable region surrounding the bla(CTX-M-9) gene in non-related Escherichia coli from BarcelonaAurora García, Ferran Navarro, Elisenda Miró, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|June 24, 2006
A simple phenotypic method for differentiation between acquired and chromosomal AmpC beta-lactamases in Escherichia coliBeatriz Mirelis, Alba Rivera, Elisenda Miró, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 2011
Prevalence of SXT/R391-like integrative and conjugative elements carrying blaCMY-2 in Proteus mirabilisCaterina Mata, Ferran Navarro, Elisenda Miró, et al.
The Journal of Antimicrobial Chemotherapy|March 21, 2006
Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarraysLina Marcela Aragón, Ferran Navarro, Volker Heiser, et al.
FEMS Microbiology Letters|June 15, 2007
Evidence for convergent evolution of CTX-M-14 ESBL in Escherichia coli and its prevalenceFerran Navarro, Rául-Jesús Mesa, Elisenda Miró, et al.
Antibiotics (Basel, Switzerland)|April 3, 2021
Taxonomic Identification of Different Species of the Genus Aeromonas by Whole-Genome Sequencing and Use of Their Species-Specific β-Lactamases as Phylogenetic MarkersXavier Bertran, Marc Rubio, Laura Gómez, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2002
Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year periodElisenda Miró, Ferran Navarro, Beatriz Mirelis, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|December 5, 2012
Characterization of aminoglycoside-modifying enzymes in enterobacteriaceae clinical strains and characterization of the plasmids implicated in their diffusionElisenda Miró, Federico Grünbaum, Laura Gómez, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Enfermedades Infecciosas Y Microbiologia Clinica|June 24, 2011
[Detection of resistance phenotypes in gram-negative bacteria]Ferran Navarro, Jorge Calvo, Rafael Cantón, et al.
Applied and Environmental Microbiology|June 11, 2013
Shiga toxin 2-encoding bacteriophages in human fecal samples from healthy individualsAlexandre Martinez-Castillo, Pablo Quirós, Ferran Navarro, et al.
The Journal of Antimicrobial Chemotherapy|September 29, 2005
Characterization of the highly variable region surrounding the bla(CTX-M-9) gene in non-related Escherichia coli from BarcelonaAurora García, Ferran Navarro, Elisenda Miró, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|June 24, 2006
A simple phenotypic method for differentiation between acquired and chromosomal AmpC beta-lactamases in Escherichia coliBeatriz Mirelis, Alba Rivera, Elisenda Miró, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 2011
Prevalence of SXT/R391-like integrative and conjugative elements carrying blaCMY-2 in Proteus mirabilisCaterina Mata, Ferran Navarro, Elisenda Miró, et al.
The Journal of Antimicrobial Chemotherapy|March 21, 2006
Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarraysLina Marcela Aragón, Ferran Navarro, Volker Heiser, et al.
FEMS Microbiology Letters|June 15, 2007
Evidence for convergent evolution of CTX-M-14 ESBL in Escherichia coli and its prevalenceFerran Navarro, Rául-Jesús Mesa, Elisenda Miró, et al.
Antibiotics (Basel, Switzerland)|April 3, 2021
Taxonomic Identification of Different Species of the Genus Aeromonas by Whole-Genome Sequencing and Use of Their Species-Specific β-Lactamases as Phylogenetic MarkersXavier Bertran, Marc Rubio, Laura Gómez, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2002
Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year periodElisenda Miró, Ferran Navarro, Beatriz Mirelis, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|December 5, 2012
Characterization of aminoglycoside-modifying enzymes in enterobacteriaceae clinical strains and characterization of the plasmids implicated in their diffusionElisenda Miró, Federico Grünbaum, Laura Gómez, et al.
Pageof 10